Back to Search Start Over

Orchid Pharma gets DCGI approval to manufacture & market antibiotic drug combination of cefepime and enmetazobactam

Source :
PharmaBiz. June 6, 2024
Publication Year :
2024

Abstract

Byline: Our Bureau Chennai-based Orchid Pharma has received Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity active pharmaceutical ingredient (API), [...]

Subjects

Subjects :
Urinary tract infections -- Drug therapy
Bacterial pneumonia -- Drug therapy
Drug therapy, Combination
Pneumonia -- Drug therapy
Drug approval
Antibiotics
Pharmaceuticals and cosmetics industries

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.796552023

Tools

Authors Abstract Subjects Details